Gene expression of circulating tumour cells in breast cancer patients

European Journal of Medical Research

Volumn 14, Issue 10, 2009, Pages 426-432

  Bolke E ^a   Orth, K ^b   Gerber, P A ^a   Lammering, G ^c   Mota, R ^a   Peiper, M ^a   Matuschek, C ^a   Budach, W ^a   Rusnak, E ^d   Shaikh, S ^e   Dogan, B ^a   Prisack, H B ^a   Bojar, Hans ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b KH Emden ^*  (Germany)

^c MAASTRO CLINIC   (Netherlands)

^d UNIVERSITY AT BUFFALO   (United States)

^e UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Gene profile; Mamma carcinoma; pcr

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LYMPHOCYTE ANTIGEN; MAMMAGLOBIN; MUCIN 1; PROTEIN GA733 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SPDEF; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; IMMUNOMAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 70350102830     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-10-426     Document Type: Article

References (48)

1. Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumour cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23: 1420-1430 (Pubitemid 46260029)
2. Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS, Jones JG. Tumour microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res. 2009; 15(7): 2433-2441
3. Nicolson GL, Dulski KM, Trosko JE. Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 1988;85:473-476
4. Welch DR, Steeg PS, Rinker-Schaeffer CW. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2000; 2: 408-416
5. Cho SY, Choi HY. Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. Am J Clin Pathol 1980;73:232-234
6. Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 1983;23:175-180
7. Mochizuki S, Umemura S, Tokuda Y, Tajima T, Mitomi T, Osamura RY. A study of 46 cumulative breast cancer autopsy cases. Tokai J Exp Clin Med 1997; 22: 19-25. (Pubitemid 127511117)
8. Siegel PM, Dankort DL, Hardy WR, Muller WJ. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumours. Mol Cell Biol 1994; 14: 7068-7077
9. Oh JJ, Grosshans DR, Wong SG, Slamon DJ. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic Acids Res 1999; 27: 4008-4017
10. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumours in transgenic mice: implications for human breast cancer. Embo J 1999;18:2149-2164
11. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumour-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286-15293 (Pubitemid 20296236)
12. Eltahir EM, Mallinson DS, Birnie GD, Hagan C, George WD, Purushotham AD. Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer 1998;77:1203-1207 (Pubitemid 28140606)
13. Lambrechts AC, van 't Veer LJ, Rodenhuis S. The detection of minimal numbers of contaminating epithelial tumour cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol 1998;9:1269-76.
14. Ghossein RA, Bhattacharya S. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000;36:1681-1694 (Pubitemid 30616372)
15. Eaton MC, Hardingham JE, Kotasek D, Dobrovic A. Immunobead RT-PCR: a sensitive method for detection of circulating tumour cells. Biotechniques 1997;22:100-105 (Pubitemid 27036422)
16. Naume B, Borgen E, Beiske K, et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997;6:103-114 (Pubitemid 27174623)
17. Hager G, Cacsire-Castillo Tong D, Schiebel I, et al. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection. Gynecol Oncol 2005;98:211-216 (Pubitemid 41019107)
18. de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A, Pouillart P, Magdelénat H. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res. 2000;6(8):3117-3122
19. Felton T, Harris GC, Pinder SE, Snead DR, Carter GI, Bell JA, Haines A, Kollias J, Robertson JF, Elston CW, Ellis IO. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1. Breast. 2004; 13(1): 35-41. (Pubitemid 38228586)
20. Zhong XY, Kaul S, Eichler A, Bastert G. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Arch Gynecol Obstet 1999; 263: 2-6. (Pubitemid 30025696)
21. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Zhong XY, Kaul S, Eichler A, Bastert G. Arch Gynecol Obstet. 1999; 263(1-2): 2-6.
22. Rao CG, Chianese D, Doyle GV, et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumours. Int J Oncol 2005; 27: 49-57.
23. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 1998; 16: 817-824 (Pubitemid 28076094)
24. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996; 56: 860-865
25. Roncella S, Ferro P, Bacigalupo B, et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J Exp Clin Cancer Res 2005; 24: 265-271 (Pubitemid 41039611)
26. Cerveira N, Torres L, Rocha P, et al. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. Int J Cancer 2004; 108: 592-595 (Pubitemid 38036661)
27. Ghadersohi A, Odunsi K, Lele S, et al. Prostate derived Ets transcription factor shows better tumour-association than other cancer-associated molecules. Oncol Rep 2004; 11: 453-458
28. Ghadersohi A, Sood AK. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumours and is a candidate breast tumour marker and a breast tumour antigen. Clin Cancer Res 2001; 7: 2731-2738 (Pubitemid 32911378)
29. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 2003; 63: 4626-4631 (Pubitemid 36951040)
30. Feldman RJ, Sementchenko VI, Watson DK. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res 2003; 23: 2125-2131
31. Modlich O, Prisack H-B, Munnes M, Audretsch W, Bojar H. Predictors of primary breast cancers responsiveness to preoperative epirubicin/ cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures. J Transl Med 2005; 3: 32. (Pubitemid 41522380)
32. Greene FL PD, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
33. Beitsch PD, Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg 2000; 180: 446-8; discussion 8-9. (Pubitemid 32166836)
34. Hu XC, Wang Y, Shi DR, Loo TY, Chow LW. Immunomagnetic tumour cell enrichment is promising in detecting circulating breast cancer cells. Oncology 2003; 64: 160-165 (Pubitemid 36173382)
35. Woelfle U, Breit E, Zafrakas K, et al. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. J Immunol Methods 2005; 300: 136-145 (Pubitemid 40805594)
36. Zippelius A, Pantel K. RT-PCR-based detection of occult disseminated tumour cells in peripheral blood and bone marrow of patients with solid tumours. An overview. Ann N Y Acad Sci 2000; 906: 110-123 (Pubitemid 30255468)
37. Grunewald K, Haun M, Urbanek M, et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest 2000; 80: 1071-1077 (Pubitemid 30483225)
38. Lin YC, Chen SC, Hsueh S, et al. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer science 2003; 94: 99-102. (Pubitemid 36575866)
39. Bostick PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 2632-2640 (Pubitemid 28363026)
40. Allard WJ, Matera J, Miller MC, et al. Tumour cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10: 6897-6904 (Pubitemid 39383039)
41. Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 4589-4594 (Pubitemid 28207957)
42. Raynor M, Stephenson SA, Walsh DC, Pittman KB, Dobrovic A. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC Cancer 2002; 2: 14.
43. Felton T, Harris GC, Pinder SE, et al. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1. Breast 2004; 13: 35-41. (Pubitemid 38228586)
44. van't Veer LJ, Paik S, Hayes DF. Gene expression profiling of breast cancer: a new tumour marker. J Clin Oncol 2005; 23: 1631-1635
45. Bölke E, Peiper M, Budach W, Matuschek C, Schwarz A, Orth K, Gripp S. (2007) Unilateral keloid formation after bilateral breast surgery and unilateral radiation Eur J Med Res. 12: 320-322
46. Matthaei H, Boelke E, Eisenberger CF, Alldinger I, Krieg A, Schmelzle M, Poremba C, Schellhammer F, Knoefel WT, Budach W, Peiper M (2008). Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumour embolization followed by elective surgery. Eur J Med Res. 4: 591-594
47. Matthaei H, Bölke E, Schmelzle M, Budach W, Orth K, Engers R, Cohnen M, Matuschek C, Gripp S, Knoefel WT, Peiper M (2008). Modern therapy of rectal carcinoma. Eur J Med Res. 13: 139-146
48. Peiper M, Bölke E, Orth K, Hosch SB, Rehders A, Matthaei A, Knoefel WT (2007) Current status of radical systematic lymphadenectomy in pancreatic cancer review of the literature Eur J Med Res 12: 47-53